Appili Therapeutics Inc. (APLIF)
Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results
FUTU HOLDINGS LTD (FUTU)
FUTU CLASS ACTION NOTICE: Glancy Prongay Wolke & Rotter LLP Files Securities Fraud Lawsuit on Behalf of Futu Holdings Limited Investors
FIRST SOLAR, INC. (FSLR)
FSLR Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against First Solar, Inc.
ResMed Inc (RMD)
ResMed Inc. Daily Stock Update
WIPRO LTD (WIT)
Capco récompensée par OpenAI pour son innovation et son leadership en matière d’IA responsable
U-HAUL HOLDING CO /NV/ (UHAL)
Utah Wildfires: U-Haul Offers 30 Days Free Storage to Evacuees of Iron and Cottonwood Fires
VANECK BITCOIN ETF (HODL)
21shares Announces Distributions on TETH, TSOL, THYP, TSUI and TDOT
ADVANCED DRAINAGE SYSTEMS, INC. (WMS)
Western Metallica Announces AGM Results
Viridian Therapeutics Inc. (VRDN)
Viridian Therapeutics, Inc. - Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa™ (veligrotug-vvze) for the Treatment of Thyroid Eye Disease
VIRIDIAN THERAPEUTICS, INC.\DE (VRDN)
Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa™ (veligrotug-vvze) for the Treatment of Thyroid Eye Disease